• Screen Shot 2015-10-06 at 4.29.54 PM

    Help SWHR win one million dollars to transform women’s health!

  • CVD-Banner

    Space is limited. Register today!

  • banner-940x376-1[1]

    SWHR launches “Beyond The Bruises” campaign highlighting the effects Of domestic violence on chronic disease

  • collins

    SWHR honors NIH Director Dr. Francis S. Collins at 25th Anniversary Gala Dinner

  • Scientist In her lab

    SWHR promotes the analysis of research data for biological and ethnic differences

  • SWHR works with researchers and clinicians to advance the field of sex-based biology.

    SWHR works with researchers and clinicians to advance the field of sex-based biology.

4Star 125x125SWHR ® is a national non-profit based in Washington D.C. that is widely recognized as the thought-leader in promoting research on biological differences in disease and is dedicated to transforming women’s health through science, advocacy, and education.

swhr updates

Pregnant Woman News

We Need to Protect Pregnant Women — and Their Babies — From Domestic Violence

Posted on 05 October 2015

Every year, an estimated 300,000 pregnant women in the U.S. experience domestic violence - and that number is believed to be vastly underreported.

Diverse Group of Women News

The Flu Shot: It’s Not Just For Kids

Posted on 24 September 2015

We all know the flu: the serious, contagious respiratory illness caused by the influenza virus that infects nearly 20 percent of Americans every year.

Shontelle Dodson News

The Society For Women’s Health Research Welcomes New Board Member

Posted on 22 September 2015

The Society for Women’s Health Research (SWHR®) is excited to announce the appointment of a new member to its Board of Directors. Joining the Board is Shontelle Dodson, PharmD, vice president of Medical Excellence within Medical Affairs, Global, at Astellas Pharma Inc.

robertcaliff News

SWHR Supports Dr. Robert Califf’s Nomination to Lead FDA

Posted on 17 September 2015

Yesterday, President Barack Obama nominated distinguished cardiologist and medical researcher Dr. Robert Califf to be the next U.S. Food and Drug Administration (FDA) Commissioner.

29000009776 News

SWHR Supports FDA Decision to Approve Female Sexual Dysfunction Treatment

Posted on 18 August 2015

The Society for Women’s Health Research (SWHR®) applauds the Food and Drug Administration (FDA) on the approval of Flibanserin, the first ever medical treatment option for Hypoactive Sexual Desire Disorder (HSDD).